3.0.0 1063 2023-01-11T13:35:11Z 2023-01-11T13:35:11Z House HR 2017-02-15 115 [Congressional Record Volume 163, Number 27 (Wednesday, February 15, 2017)]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. O'ROURKE:H.R. 1063.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clause 18:To make all Laws which shall be necessary and proper forcarrying into Execution the foregoing Powers, and all otherPowers vested by this Constitution in the Government of theUnited States, or in any Department or Officer thereof.[Page H1244]]]> hsvr00 Veterans' Affairs Committee House Standing hsvr03 Health Subcommittee Hearings by 2017-09-26T15:24:50Z Referred to 2017-03-03T14:04:52Z Referred to 2017-02-15T15:01:20Z 2017-09-26 hsvr03 Health Subcommittee 1 House committee actions Subcommittee Hearings Held. Committee 2017-03-03 hsvr03 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2017-02-15 Referred to the House Committee on Veterans' Affairs. IntroReferral H11100 2 House floor actions hsvr00 Veterans' Affairs Committee 2017-02-15 Introduced in House IntroReferral Intro-H 9 Library of Congress 2017-02-15 Introduced in House IntroReferral 1000 9 Library of Congress O000170 Rep. O'Rourke, Beto [D-TX-16] Beto O'Rourke D TX 16 N C001077 Rep. Coffman, Mike [R-CO-6] Mike Coffman R CO 6 2017-02-15 True J000255 Rep. Jones, Walter B., Jr. [R-NC-3] WALTER JONES R NC B. 3 2017-02-15 True P000608 Rep. Peters, Scott H. [D-CA-52] Scott Peters D CA H. 52 2017-02-15 True R000602 Rep. Rice, Kathleen M. [D-NY-4] Kathleen Rice D NY M. 4 2017-02-15 True T000468 Rep. Titus, Dina [D-NV-1] Dina Titus D NV 1 2017-02-15 True G000289 Rep. Goodlatte, Bob [R-VA-6] ROBERT GOODLATTE R VA W. 6 2017-03-29 False Armed Forces and National Security Military medicine Prescription drugs Veterans' medical care Armed Forces and National Security 00 2017-02-15 Introduced in House 2017-03-04T15:26:18Z Veteran Prescription Continuity Act

This bill amends the National Defense Authorization Act for Fiscal Year 2016 to direct the Department of Veterans Affairs (VA) to furnish an individual who is transitioning from Department of Defense (DOD)- to VA-furnished medical treatment any pharmaceutical agent not included in the joint uniform formulary if a DOD health care provider determines that the pharmaceutical agent is critical for the transition.

The VA shall furnish an individual with such pharmaceutical agent: (1) beginning when the individual enrolls in the VA health care system, and (2) ending when a DOD health care provider determines that the individual does not require the pharmaceutical agent.

]]> Veteran Prescription Continuity Act Display Title Veteran Prescription Continuity Act Official Title as Introduced To ensure that an individual who is transitioning from receiving medical treatment furnished by the Secretary of Defense to medical treatment furnished by the Secretary of Veterans Affairs receives the pharmaceutical agents required for such transition. Introduced in House IH Short Titles as Introduced Veteran Prescription Continuity Act Introduced in House 2017-02-15T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-115hr1063ih/xml/BILLS-115hr1063ih.xml 2017-09-26 Subcommittee Hearings Held. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.